Carfilzomib (PR-171) is an irreversible proteasome inhibitor with IC50 of <5 nM in ANBL-6 cells, displayed preferential in vitro inhibitory potency ag... Quality confirmed by NMR & HPLC. See customer reviews, validations & product citations.
read more..